SIS  |  Surgical and Interventional Sciences Program

Leadership and Management

The Surgical and Interventional Sciences (SIS) Program has a management committee made up of the program leadership, theme leaders and SIS representatives, as well as external members. The committee meets twice a year to streamline priorities and objectives, including its annual retreat.


Dr. Edward HarveyProgram Leader

Jake Barralet, B.Eng. (Hons), PhDAssociate Program Leader

Anne Mathiot, Program Manager

Dr. Jason Harley, Co-leader, Surgical Education and Simulation

Dr. Melina Vassiliou, Co-leader, Surgical Education and Simulation

To Be Confirmed, Leader, Regenerative Medicine

Dr. Julio Fiore, Leader, Surgical Outcomes and Quality

Dr. Liane Feldman, Chair of the Department of Surgery, McGill University

Dr. Gerald Fried, Director of the Steinberg Centre for Simulation and Interactive Learning (SCSIL)

Dr. Amir Hooshiar, Director of the Surgical Performance Enhancement and Robotics (SuPER) Centre

TBC, EDI representative

TBC, Student representative


Program leaders and manager
Edward Harvey, MDCM, M.Sc.Edward Harvey, MDCM, M.Sc., is a professor of surgery at McGill University, where he earned his medical degree. His research interests in fundamental and clinical aspects of bone healing include implant and fracture optimization, stem cells, outcome evaluation after surgery, biosensors and evaluation of novel hardware and surgical approaches to expedite repair. He collaborates with basic, clinical and engineering scientists and has ongoing industry collaborations, particularly in the field of micro-electromechanical systems (MEMS) and sensors. His funding sources include the Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council of Canada (NSERC), Orthopaedic Trauma Association (OTA), AO Foundation, MITACs and the Leukemia & Lymphoma Society (Canada and the U.S.). Dr. Harvey has had multiple responsibilities on executive and research committees of the OTA, the American Academy of Orthopaedic Surgeons (AAOS), the Orthopaedic Research Society (ORS) and the Canadian Orthopaedic Association (COA). He is, or has been, editor-in-chief of the Canadian Journal of Surgery and JBJS Trauma Newsletter; editorial board member of the Journal of Orthopaedic Trauma; chairman of the Research Committee and of the Annual Basic Science Course of the OTA; member of the Board of Specialty Societies Research Committee, AAOS; chair of the Trauma Section, ORS; and president of the COA.

Jake Barralet, PhDJake Barralet, PhDis a professor of biomaterials and Director of Research in Orthopaedic Surgery at McGill University, and the Vice-Chair of Research, Department of Surgery, at the McGill University Health Centre. With more than 15 years of academic and industrial experience in biomaterials and nanotechnology, his research interests include tissue regeneration, 3D printed bioceramics, nanomedecine and controlled release of bioactives. He is an active board member of the Canadian Society for Pharmaceutical Sciences and of the Canada Local Chapter of the Controlled Release Society, which he established four years ago. He is interested in productive partnerships focused on bringing new innovations to the public. In 2016 he received funding from the Natural Sciences and Engineering Research Council of Canada to provide nearly 90 students with cross-disciplinary training to prepare them for high-skill jobs in the surgical devices industry.

Anne Mathiot, M.Sc. Anne Mathiot, M.Sc., joined the Research Institute of the McGill University Health Centre (RI-MUHC) in September 2022 as program manager of the Injury Repair Recovery Program and Clinical Innovation Platform – the first incubator for cutting-edge health technologies at the RI-MUHC and McGill University. Previously, she held positions in research for organizations in England and Canada, including project manager at Imperial College London and research centre manager at University College London. She has learned to collaborate with research organizations as well as private companies to support interdisciplinary research and innovation. She obtained an bachelor’s degree in engineering in France before graduating with an M.Sc. in immunotoxicology from the Université du Québec à Montréal in Canada. Her academic and professional journey highlights her interest and experience in medical and translational research.